Author

E. Caballé-Pérez

h-index 7 View on Semantic Scholar

We have 3 of 37 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Adult IDH-wildtype glioblastoma in Mexico and Latin America: contemporary standards, emerging strategies, and an evidence-to-implementation roadmap

Glioblastoma remains a major therapeutic challenge, and disparities in diagnostic capacity, treatment access, and continuity of care may further limit outcomes in Mexico and Latin America. This structured narrative review examines contemporary management of glioblastoma in adults, focusing on implementation of evidence...

A. Rodríguez-Camacho, Emmanuel Polito-Salazar, Ximena Blasco et al. · Frontiers in Oncology · 0 citations

Review Open access Aug 2026

DNA Damage Repair Genes in Lung Cancer: Diagnostic, Prognostic, and Therapeutic Implications- A Narrative Review.

Lung cancer management remains constrained by a fragmented understanding of the clinical implications of DNA Damage Response (DDR) pathways. This review synthesizes current evidence to position DDR alterations as potential prognostic, predictive, and therapeutic biomarkers. Prognostically, overexpression of FEN1, BRCA1...

Ana-Karla Durán-Toribio, Ignacio F Jiménez-Díaz, E. Caballé-Pérez et al. · Critical reviews in oncology... · 0 citations

Review Sep 2026

Innovative Therapies for HER2-altered Non-Small Cell Lung Cancer: a Narrative Review.

A narrative review summarizes the clinicopathological features of HER2-altered NSCLC, critically evaluates emerging HER2-targeted therapies, and discusses future treatment directions.

Oscar Arrieta, E. Caballé-Pérez, L. Cabrera-Miranda et al. · Critical reviews in oncology... · 0 citations